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Background. This study was undertaken to ascertain the ef-
fect of dietary modification on urinary stone risks, and to deter-
mine whether the response depends on the prevailing urinary
calcium.
Methods. A retrospective data analysis was conducted from
our stone registry involving 951 patients with calcareous stones
undergoing ambulatory evaluation, whereby 24-hour urine
samples were collected during random diet and after di-
etary modification composed of restriction of calcium, ox-
alate, sodium, and meat products. Samples were analyzed for
stone risk factors. Urinary calcium was also obtained after
overnight fast and following a 1 g-calcium load. Changes pro-
duced by dietary modification from the random diet were
evaluated in 356 patients with moderate-severe hypercalciuria
(>6.88 mmol/day, group I), 243 patients with mild hypercalci-
uria (5.00–6.88 mmol/day, group II), and 352 with normocalci-
uria (<5.00 mmol/day, group III).
Results. Urinary calcium postcalcium load and the percentage
of patients with absorptive hypercalciuria type I were highest
in group I, intermediate in group II, and lowest in group III.
During dietary modification, urinary calcium declined by 29%
in group I, 19% in group II, and 10% in group III. Urinary
oxalate did not change. Urinary saturation of calcium oxalate
declined by only 12% in group I, 6% in group II, and nonsignif-
icantly in group III, owing to various physicochemical changes
in urinary biochemistry, which attenuated the effect of the de-
cline in urinary calcium. Urinary saturation of brushite declined
in all 3 groups due to the fall in urinary calcium, phosphorus,
and pH. This reduction was more marked in the hypercalciuric
groups than in the normocalciuric group. Urinary saturation
of monosodium urate also decreased from a decline in urinary
sodium and uric acid.
Conclusion. Secondary rise in urinary oxalate occurring from
calcium restriction can be avoided by concurrent dietary oxalate
restriction. Dietary modification (restriction of dietary calcium,
oxalate, sodium, and meat products) is more useful in reducing
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urinary saturation of calcium oxalate among patients with hy-
percalciuria than among those with normocalciuria.
There is some uncertainty regarding the value of di-
etary calcium restriction in the management of calcium
nephrolithiasis. Epidemiologic studies in the 1990s show-
ing the protective effect of dietary calcium on stone for-
mation have led to the reexamination of the widely held
practice of dietary calcium restriction [1, 2]. A recent ran-
domized trial disclosed that a diet restricted in sodium
and animal proteins but liberal in calcium and fruit prod-
ucts is more effective than a diet restricted in calcium in
preventing stone formation [3].
However, a metabolic study [4] showed that the pro-
tective effect of high dietary calcium may have resulted
from concurrent increased intake of protective dietary
factors—fluids, potassium, and magnesium. The afore-
mentioned diet trial [3] lacked an appropriate control
group for the low calcium diet, since the two diets dif-
fered in more than their calcium content. Moreover, a
detailed examination of data from our stone registry in-
dicated that urinary calcium was equally important as
urinary oxalate in determining urinary saturation of cal-
cium oxalate among patients with predominantly calcium
oxalate stones [5]. Among those with calcium phosphate
stones, urinary calcium was a key determinant of urinary
saturation of brushite (CaHPO4 • H2O), but urinary ox-
alate was not [6]. In normal subjects, calcium carbonate
supplementation increased urinary saturation of calcium
oxalate [7], but this rise was attenuated by calcium cit-
rate supplementation [8, 9]. Among patients with stones
suffering from absorptive hypercalciuria type I (AH-I)
with enhanced intestinal calcium absorption, a high cal-
cium intake produced a much more marked increase in
urinary calcium than in normal subjects [10].
The apparently conflicting reports described above
have led to a general confusion regarding the recommen-
dation for calcium intake during the management of stone
disease. Multiple factors can potentially influence the way
calcium intake modifies urinary saturation of calcium ox-
alate. A change in calcium content of the diet is often
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accompanied by alteration in other components [1, 2, 4].
The dietary recommendation for the control of stone for-
mation often imposes changes in other food components
besides calcium-rich foods [3], such as oxalate, sodium
[11], and purines. Moreover, the response to alteration in
calcium intake depends on the prevailing intestinal cal-
cium absorption of the patients [10].
In order to identify the effects the various factors that
modify the action of dietary calcium described above, and
to seek a rational basis for dietary management in calcium
nephrolithiasis, we conducted a retrospective data anal-
ysis of urinary stone risks from 951 patients with stones
who underwent a detailed ambulatory evaluation [13].
This evaluation involved collection of 24-hour samples
before and after a dietary modification that comprised a
restriction of calcium, oxalate, sodium, and meat. Patients
were divided into 3 groups according to 3 ranges of uri-
nary calcium excretion during the random diet. By com-
paring the effect of this dietary modification on urinary
stone risk factors between the 3 groups, it was possible
to examine interaction between various dietary changes
and to test the hypothesis that the beneficial effect of di-
etary modification depended on the presence or absence
of, and the degree of, hypercalciuria.
METHODS
Patient data
From our stone registry of 2200 patients with stones
who underwent our ambulatory evaluation [13], data
were retrieved from patients who satisfied the follow-
ing entry criteria: (1) ≥18 years of age of either gen-
der or ethnicity; (2) availability of stone analysis; (3)
stone composition showing calcium oxalate and/or cal-
cium phosphate (hydroxyapatite or brushite); (4) 1 or
2 24-hour urine collections on a “random diet,” and a
24-hour urine collection on a “restricted diet” for the
analysis of stone risk factors [14]; and (5) adequacy
of urine collection, indicated by urinary creatinine ±
30% of idealized urinary creatinine (22.1 mg/kg in men
and 17.2 mg/kg creatinine in women) [15]. Exclusion
criteria were: (1) stone composition showing struvite,
carbonate apatite, or tricalcium phosphate; (2) infec-
tion of the urinary tract with urea-splitting organisms;
(3) primary hyperparathyroidism or hypercalcemia; and
(4) moderate-severe chronic diarrheal syndrome due to
organic diseases of the bowel (ileal resection, bypass
surgery, Crohn’s disease, fat malabsorption).
Nine hundred and fifty-one patients satisfied the above
criteria. They were divided into 3 groups, based on
24-hour urinary calcium during the random diet. Group I
(moderate-severe hypercalciuria) comprised patients
whose urinary calcium exceeded 6.88 mmol (275 mg)/day.
Patients in group II (mild hypercalciuria) had urinary
calcium ranging from 5.00 to 6.88 mmol/day (200–
275 mg/day). Group III (normocalciuria) were those with
urinary calcium <5.00 mmol (200 mg)/day. In each group,
the following data were extracted: gender, age, height,
weight, percentage of patients with predominantly cal-
cium oxalate stones (>70% calcium oxalate) and per-
centage with calcium phosphate stones (≥30% calcium
phosphate), family history of stones (not distinguished
according to stone type), and history of stone recurrence.
Ambulatory protocol
Employed in Dallas since 1978, this protocol entailed
evaluation of patients during their usual diet (random
diet) and following 1 week of adherence to a restricted
diet limited in calcium (10 mmol or 400 mg/day), oxalate,
sodium (100 mmol/day), and meat products [13]. Patients
were instructed on the restricted diet by a dietician or a
trained nurse by using a published diet instruction sheet
[15]. Calcium restriction was achieved by avoidance of
milk and dairy products, oxalate restriction by avoidance
of tea, chocolate, dark roughages, and nuts; and sodium
restriction by avoiding use of salt shakers and salty pre-
pared foods. Meat intake was limited to 2 (3 oz) servings
per day or approximately 168 g of protein per day. Pa-
tients were asked to stop calcium supplements or any
drug that could affect the metabolism of calcium, uric
acid, or oxalate, for at least 1 week before and during
each urine collection. Prior to referral to our center for
evaluation, the patients were commonly advised by other
physician(s) to restrict calcium intake and increase fluid
ingestion, and less commonly, to reduce the intake of salt,
meat products, and oxalate-rich foods.
During both diets, urine samples were collected in
24-hour pools for stone risk factors [14], which in-
cluded calcium, oxalate, citrate, phosphorus, uric acid,
pH, sodium, potassium, magnesium, and total volume.
Some tests (sulfate, chloride, and ammonium) were not
measured in all patients, since they were introduced to
the assay profile at various times since the introduction
of the study protocol in 1978. Some patients collected 2
random urine samples; the mean value for various stone
risk factors was employed in the data to be presented.
Following the 24-hour urine collection on the restricted
diet, patients underwent the study of “fast and calcium
load” [16], whereby they collected a 2-hour urine sample
after an overnight fast and a 4-hour urine sample fol-
lowing an oral load of 1 g calcium. Urine samples were
analyzed for calcium and creatinine. A fasting serum sam-
ple was also obtained and analyzed for creatinine. Fasting
and post-calcium load urinary calcium was expressed as
lmol/dL glomerular filtrate (GF) by multiplying urinary
calcium in lmol/mmol creatinine by serum creatinine in
mmol/dL.
From the above tests, the diagnosis of various stone-
forming conditions was made using the previously
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published criteria [17]. AH-I was defined as urinary cal-
cium >5.00 mmol/day on both random and restricted di-
ets, and a postload urinary calcium >5 lmol/dL GF. High
fasting urinary calcium (>2.75 lmol/dL GF) was allowed
in order to include patients with severe AH with fasting
hypercalciuria. Hyperuricosuric calcium oxalate urolithi-
asis (HUCU) represented urinary uric acid >3.57 mmol
(600 mg)/day on all urine samples or for the mean, with
urinary pH >5.5. In hypocitraturia, mean urinary citrate
was <1.67 mmol (320 mg)/day.
Estimation of the intake of calcium, oxalate, sodium, and
meat during the random diet
At evaluation, diet history was taken regarding the in-
take of key ingredients during the usual diet [15]. From
all patients, this history was reviewed by a metabolic di-
etitian (L.J.B.) or a trained research nurse (R.D.P.), in
order to categorize each intake into “mild,” “moderate,”
and “high.” Accordingly, for dietary calcium, avoidance
of milk and dairy products as in the instructed diet con-
stituted a low intake, some ingestion a moderate intake,
and liberal ingestion represented a high intake. For di-
etary oxalate, avoidance of oxalate-rich foods as in the in-
structed diet indicated a low intake, consumption of some
represented a moderate intake, and liberal consumption
constituted a high intake. For dietary sodium, a low in-
take as in the instructed diet represented avoidance of
salt shakers and salty foods, a moderate intake allowed
some, and a high intake indicated liberal use. For meat
intake, 2 servings per day represented a moderate intake
as in the instructed diet, <2 servings a low intake, and >2
servings indicated a high intake. This categorization was
independently evaluated by both investigators in selected
patients to assure close corroboration.
Calculation of activity products
From urinary stone risk factors, relative saturation ra-
tio (RSR) of calcium oxalate, brushite, and monosodium
urate, and undissociated uric acid [18] were calculated
by using the Equil 2 computer program (Department of
Urology, University of Florida) [19]. RSR, the ratio of
activity product and thermodynamic solubility product,
was used to depict urinary saturation because it was con-
veniently expressed as whole numbers.
The calculation of activity product from urinary stone
risk factors is briefly described here, illustrated for cal-
cium oxalate. It should be noted that the urinary satura-
tion of calcium oxalate is defined by the activity product
(aCa2+ × aOx2−), not by the product of total or ionic cal-
cium and oxalate concentrations.
aCa2+×aOx2− = [Ca2+]c ×[Ox2−]c
where aCa2+ is the activity of calcium ion, aOx2− is activity
of oxalate ion, [Ca2+] the concentration of calcium ion,
[Ox2−] concentration of oxalate ion, and c is the activ-
ity coefficient. [Ca2+] is the total calcium concentration
minus the concentration of soluble complexes principally
of calcium-oxalate and calcium-citrate. [Ox2−] is the to-
tal oxalate concentration minus the concentration of solu-
ble calcium-oxalate complexes. c is an inverse function of
ionic strength that is determined by the amount of cations
and anions. aCa2+ is defined by the product of [Ca2
+] and
c. aOx2− is obtained as the product of [Ox2−] and c.
In the Equil 2 program [19], the computer computes
the amount of soluble complexes by using stability con-
stants, and derives [Ca2+] and [Ox2−] by subtracting re-
spective complexes from experimentally derived total
calcium and oxalate concentrations. It also calculates c
from urinary analytes derived from stone risk analysis
by using Debye-Huckel limiting law. When determining
the activity products of brushite and monosodium urate,
the concentrations of divalent phosphate (HPO42−) and
monovalent urate are obtained from the respective disso-
ciation constants and pH. The computer program repeats
these procedures (iterations), until a tight fit of data is
obtained.
Statistical analysis
One way analysis of variance (ANOVA) was used
to assess significant differences in laboratory data ob-
tained during the random diet between the 3 groups.
When ANOVA reached significance, individual compar-
ison between groups was made by least squares means
probabilities with Bonferoni corrections. For each group,
paired t tests were used to assess significant differences
between the random diet and restricted diet. For ordered
categorical analysis (estimate of dietary intakes), over-
all group comparisons and pairwise comparisons were
made with the Mantel-Haenszel correlation statistic. For
stone type, family history of stones, stone recurrence, and
percentage of various diagnoses, group differences were
assessed with the chi-square test. Statistical analysis was
performed with SAS 9.1 (SAS Institute, Cary, NC, USA).
Results are expressed as mean ± standard deviation.
RESULTS
Comparison of the 3 groups
There were 356 patients in group I, 243 in group II,
and 352 in group III (Table 1). While there were more
men than women in all 3 groups, the male predominance
was most marked in group I and least marked in group
III. While age did not differ, the body height, weight,
and body mass index (BMI) were higher in group I than
group II, and in group II than group III. In all 3 groups,
the vast majority of patients had predominantly calcium
oxalate stones (∼90%) rather than calcium phosphate
stones. About one half of patients gave a positive family
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Table 1. Demography and baseline presentation
Group I Group II Group III ANOVA P
No. patients 356 243 352
Gender M/F 288/68 170/73 208/144
Age 43.0 ± 10.8 41.8 ± 12.6 42.1 ± 12.3 0.4
Height cm 175 ± 9 173 ± 9a 170 ± 9a,b <0.0001
Weight kg 86.7 ± 17.5 78.6 ± 15a 72.8 ± 15.9a,b <0.0001
BMI kg/m2 28.2 ± 5.4 26.2 ± 4.4a 25.1 ± 4.9a,b <0.0001
CaOx stones% pts 92.1 89.5 89.9 0.9
CaP stones% pts 7.9 10.5 10.1 0.4
Family history of stones% pts 54.2 57.6 52.0 0.4
Stone recurrence% pts 90.4 91.5 86.9 0.15
Ca intake% pts Low/Moderate/High 11.8/36.1/52.1 14.2/60.8/25.0a 31.8/57.3/11.0a,b <0.0001
Ox intake% pts Low/Moderate/High 14.0/52.8/33.2 18.7/57.1/25.2 18.9/58.9/22.2a 0.002
Na intake% pts Low/Moderate/High 18.1/40.4/41.5 27.0/46.5/26.6a 32.8/45.2/22.0a <0.0001
Meat intake% pts Low/Moderate/High 4.7/42.9/52.5 7.9/55.8/36.3a 14.5/57.2/28.3a <0.0001
Fasting Ca lmol/dL GF 2.5 ± 1.7 2.2 ± 1.2a 1.7 ± 1.0a,b <0.0001
Load Ca lmol/dL GF 7.0 ± 3.0 6.0 ± 2.2a 5.0 ± 2.2a,b <0.0001
Diagnosis, no. (%)
AH-I 262 (73.6) 153 (63.0)a 0 (0)a,b <0.0001
HUCU 213 (59.8) 94 (38.7)a 88 (25.0)a,b <0.0001
Hypocitraturia 99 (27.8) 96 (39.5)a 173 (49.1)a <0.0001
Urinary Ca mmol/day 9.18 ± 2.00 5.89 ± 0.52a 3.62 ± 1.05a,b <0.0001
Cr clearance mL/min 3.07 ± 0.80 2.72 ± 0.60a 2.45 ± 0.95a,b <0.0001
Abbreviations: Ox, oxalate; Pts, patients; P, phosphate. Group I, urinary calcium >6.88 mmol/day. Group II, urinary calcium 5.00 to 6.88 mmol/day. Group III, urinary
calcium <5.00 mmol/day. Values are presented as mean ± SD. Dietary intakes indicate estimates for the random diet.
a P < 0.017 vs. group I; bP < 0.017 vs. group II.
history of stones, and most patients were recurrent stone-
formers.
There were statistically significant group differences
in the estimated intake of calcium, oxalate, sodium, and
meat during the random diet (Table 1). The percentage
of patients on high intake of calcium, oxalate, sodium,
or meat was largest in group I, intermediate in group II,
and smallest in group III. Conversely, the percentage of
patients on low intake of these constituents was largest
in group III, intermediate in group II, and smallest in
group I. The majority of patients in each group took more
calcium, oxalate, and sodium during the random diet than
during the instructed diet for restricted urine collection.
More calcium was taken during the random diet than
restricted diet in 88% of patients in group I, 86% in group
II, and 68% in group III. More oxalate was taken during
random than restricted diet in 86% in group I, 82% in
group II, and 81% in group III. More sodium was ingested
during random than restricted diet in 82% in group I, 73%
in group II, and 67% in group III. For meat consumption,
the majority of patients in groups II and III were already
on either low or moderate meat intake (63.7% and 71.7%
for group II and group III, respectively). In group I, 47.6%
were on low or moderate meat intake during the random
diet.
Urinary calcium during fast and post-calcium load was
highest in group I and lowest in group III (Table 1). AH-
I was disclosed in a majority of patients in group I and
group II, but was absent in group III. HUCU was encoun-
tered in a majority of patients in group I; a smaller num-
ber of patients suffered from this condition in group III
Table 2. Comparison of random and restricted diets in group I with
urinary calcium >6.88 mmol/day
Random diet Restricted diet P value
TV mL 2081 ± 918 1963 ± 954 0.002
pH 5.99 ± 0.39 5.94 ± 0.41 0.01
Ca mmol/day 9.18 ± 2.00 6.54 ± 2.35 <0.0001
Ox mmol/day 0.408 ± 0.141 0.392 ± 0.160 0.0635
Cit mmol/day 3.01 ± 1.39 2.70 ± 1.36 <0.0001
Mg mmol/day 4.95 ± 1.62 4.14 ± 1.49 <0.0001
P mmol/day 35.7 ± 9.9 31.5 ± 10.4 <0.0001
Na mmol/day 208 ± 76 125 ± 64 <0.0001
K mmol/day 57.3 ± 19.6 53.6 ± 21.8 0.0003
UA mmol/day 4.05 ± 1.20 3.98 ± 1.49 0.4
SO4 mmol/day 24.4 ± 9.2 23.4 ± 9.5 0.1
NH4 mEq/day 42.8 ± 17.4 43.3 ± 15.3 0.8
Cr mmol/day 15.9 ± 3.6 15.8 ± 3.8 0.3
RSR CaOx 9.94 ± 4.22 8.76 ± 3.94 <0.0001
RSR Br 3.21 ± 1.79 2.22 ± 1.65 <0.0001
RSR NaU 3.81 ± 2.46 2.69 ± 2.35 <0.0001
H2U mmol/day 0.839 ± 0.571 0.899 ± 0.625 0.1
Abbreviations are: Ox, oxalate; Cit, citrate; UA, uric acid; Cr, creatinine; RSR,
relative saturation ratio; CaOx, calcium oxalate; Br, brushite; NaU, monosodium
urate; H2U, undissociated uric acid.
than in group II. Conversely, the prevalence of hypocitra-
turia was lowest in group I (28%) and highest in group III
(49%).
Urinary calcium on a random diet was highest in
group I, intermediate in group II, and lowest in group III
(Table 1). A similar pattern was noted in urinary oxalate,
citrate, magnesium, phosphorus, sodium, uric acid, and
endogenous creatinine clearance (P < 0.002 by ANOVA)
(Tables 2–4).
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Table 3. Comparison of random and restricted diets in group II with
urinary calcium 5.00 to 6.88 mmol/day
Random diet Restricted diet P value
TV mL 1795 ± 852 1727 ± 851 0.1
pH 6.03 ± 0.39 5.97 ± 0.44 0.02
Ca mmol/day 5.89 ± 0.52 4.74 ± 1.62 <0.0001
Ox mmol/day 0.364 ± 0.133 0.344 ± 0.127 0.1
Cit mmol/day 2.62 ± 1.34 2.27 ± 1.26 <0.0001
Mg mmol/day 4.05 ± 1.30 3.50 ± 1.37 <0.0001
P mmol/day 29.1 ± 7.5 27.1 ± 8.8 0.0003
Na mmol/day 170 ± 63 108 ± 50 <0.0001
K mmol/day 51.1 ± 18.2 45.3 ± 18.5 <0.0001
UA mmol/day 3.48 ± 1.01 3.32 ± 1.20 0.02
SO4 mmol/day 19.6 ± 7 20.3 ± 10.1 0.2
NH4 mEq/day 33.9 ± 11.8 40.8 ± 15.8 0.0001
Cr mmol/day 14.1 ± 3.4 14.1 ± 3.5 0.6
RSR CaOx 8.62 ± 4.01 8.09 ± 3.62 0.04
RSR Br 2.64 ± 1.72 2.07 ± 1.89 <0.0001
RSR NaU 4.07 ± 2.97 2.92 ± 2.66 <0.0001
H2U mmol/day 0.673 ± 0.476 0.708 ± 0.446 0.2
Abbreviations are the same as in Table 2.
Table 4. Comparison of random and restricted diets in group III with
urinary calcium <5.00 mmol/day
Random diet Restricted diet P value
TV mL 1581 ± 694 1618 ± 773 0.3
pH 6.01 ± 0.44 5.96 ± 0.43 0.04
Ca mmol/day 3.62 ± 1.05 3.24 ± 1.37 <0.0001
Ox mmol/day 0.363 ± 0.215 0.355 ± 0.224 0.8
Cit mmol/day 2.15 ± 1.27 2.05 ± 1.21 0.3
Mg mmol/day 3.40 ± 1.53 3.18 ± 1.25 0.002
P mmol/day 25.7 ± 7.7 23.7 ± 7.9 <0.0001
Na mmol/day 147 ± 59 102 ± 51 <0.0001
K mmol/day 46.1 ± 17.4 43.3 ± 17.3 0.002
UA mmol/day 3.10 ± 1.01 3.08 ± 1.18 0.9
SO4 mmol/day 16.6 ± 7.3 17.3 ± 7.9 0.1
NH4 mEq/day 32.4 ± 16.1 34.4 ± 13.2 0.1
Cr mmol/day 12.6 ± 3.5 13.0 ± 3.8 0.3
RSR CaOx 6.88 ± 4.33 6.57 ± 3.58 0.09
RSR Br 1.73 ± 1.52 1.43 ± 1.35 <0.0001
RSR NaU 3.71 ± 3.12 2.74 ± 2.63 <0.0001
H2U mmol/day 0.696 ± 0.530 0.702 ± 0.524 0.6
Abbreviations are the same as in legend to Table 2.
Serum calcium, phosphorous, total CO2 content, and
parathyroid hormone (PTH) concentrations were not sig-
nificantly different between groups (data not shown).
Effect of dietary modification on urinary calcium
and oxalate
Urinary calcium was significantly lower on the re-
stricted diet than on the random diet in all 3 groups (Fig. 1,
Tables 2–4). The decline in urinary calcium of 29% was
greatest in group I with moderate-severe hypercalciuria,
intermediate at 19% in group II with mild hypercalciuria,
and least pronounced at 10% in group III with normo-
calciuria. In contrast, urinary oxalate was not significantly
different between random and restricted diets in any of
3 groups.
Effect of calcium oxalate on urinary saturation
Urinary citrate was significantly lower on the restricted
diet than on the random diet in groups I and II (Fig. 1,
Tables 2–4). Urinary sodium was significantly lower on
the restricted diet in all 3 groups.
Figure 2 displays critical physicochemical factors that
determine urinary saturation of calcium oxalate, calcu-
lated and derived from the Equil 2 program [20]. The
amount of soluble calcium-oxalate complex was signif-
icantly lower during restricted diet than on the random
diet in groups I and II (Fig. 2), owing to a decline in urinary
calcium without a change in urinary oxalate (Fig. 1). The
amount of calcium-citrate complexes also decreased with
the imposition of restricted diet, since both calcium and
citrate declined. Activity coefficient was higher during
the restricted diet than on the random diet, due largely to
the lower urinary sodium. Associated with these changes,
activity of calcium ion (aCa2+) decreased and activity of
oxalate ion (aOx2−) increased during dietary restriction.
Urinary RSR of calcium oxalate was significantly lower
on the restricted diet than on random diet in groups I and
II; however, the decline in RSR (of 12% and 6%) was less
marked than the fall in urinary calcium (of 29% and 19%)
(Fig. 2 vs. Fig. 1). There was no significant difference in the
RSR of calcium oxalate between the two diets in group
III, despite a 10% decrease in urinary calcium.
Effect of brushite and urate on urinary saturation
There was a small but significant decline in urinary
phosphorus and pH with dietary restriction (Fig. 3,
Tables 2–4). RSR of brushite declined significantly in all 3
groups. The decline was 31% in group I, 22% in group II,
and 17% in group III.
Urinary uric acid did not change or decreased
slightly with dietary restriction (Fig. 3). Urinary RSR of
monosodium urate declined significantly in all 3 groups,
but the amount of undissociated uric acid did not change.
DISCUSSION
This retrospective data analysis from our stone reg-
istry was undertaken in order to examine the effect
of dietary modification (restricted in calcium, oxalate,
sodium, and meat products) on urinary stone risk fac-
tors, and to identify patient population who might be
most amenable to dietary management. Overall, dietary
modification reduced urinary calcium, moreso among pa-
tients with moderate-severe hypercalciuria than among
those with mild hypercalciuria and normocalciuria, but
it did not change urinary oxalate owing to concurrent
oxalate restriction. Urinary citrate decreased (probably
from reduced alkali load) and urinary sodium substan-
tially decreased (from salt restriction). Above changes in
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Fig. 1. Effect of dietary modification on uri-
nary calcium, oxalate, citrate, and sodium in
the 3 groups. Group I = urinary calcium dur-
ing random diet >6.88 mmol/day; group II =
urinary calcium 5.00 to 6.88 mmol/day; group
III = urinary calcium <5.00 mmol/day. Hor-
izontal lines above the bars indicate mean ±
SD. Dagger symbol indicates P < 0.001 be-
tween random and restricted diets.
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Fig. 2. Effect of dietary modification on calcium-oxalate complex, calcium-citrate complexes, activity coefficient, activity of calcium ion (Ca2+),
activity of oxalate (aOx2− ), and relative saturation ratio (RSR) of calcium oxalate.
∗∗P < 0.01 between the 2 diets.
urinary constituents modified the amount of soluble com-
plexes of calcium oxalate and calcium citrate as well as the
activity coefficient of urine, thereby altering the activity of
calcium and oxalate ions that determine the saturation of
calcium oxalate. Thus, the decline in RSR of calcium ox-
alate was less marked than that of urinary calcium, with a
mild-modest decline among patients with hypercalciuria
but no significant change in those with normocalciuria.
Dietary modification also reduced urinary phosphorus
and pH, reducing urinary saturation of brushite.
The original intent of the dietary modification was to
simulate in an outpatient setting with an instructed diet,
a constant metabolic dietary regimen accomplished in
the inpatient setting of the General Clinical Research
Center. The similarity of 24-hour, fasting, and postload
urinary calcium between the 2 diets [20] justified the use
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Fig. 3. Effect of dietary modification on urinary phosphorus (P), pH, RSR brushite, uric acid, RSR of monosodium urate (Na Urate), and
undissociated uric acid. ∗P < 0.05 between the 2 diets.
of an instructed diet for the evaluation of patients with
urolithiasis in an ambulatory setting, particularly for the
differentiation of hypercalciurias.
The dietary modification used here imposed not only a
restricted intake of calcium, but also of oxalate, sodium,
and meat products. This diet is not overly difficult to fol-
low because it entailed mainly the avoidance of dairy
products, oxalate-rich foods, and use of salt shakers. For
this reason, it had been recommended as the basic di-
etary program that might be modified for specific needs
during long-term management of recurrent urolithiasis
[21]. There is general agreement that dietary restriction
of oxalate, sodium, and meat products is beneficial in the
control of stone disease [3]. While the dietary modifica-
tion did not include increased intake of fruit products,
it was felt that potassium citrate may serve the needs
of potassium-rich citrus fruits, without the disadvantages
of increased calories and mild oxaluric action of fruit
products [22]. Regarding calcium intake, we had rec-
ommended earlier empirically that a calcium restriction
might be imposed among patients with hypercalciuria in
the absence of bone loss [21].
This study was directed toward redressing current un-
certainty regarding calcium intake in the management
of calcium nephrolithiasis. Broad dietary modification
with changes in dietary composition other than calcium
can modify urinary calcium as well as other urinary con-
stituents that could alter urinary saturation of stone-
forming salts [11, 12, 22, 23]. Moreover, a substantial
fraction of patients with urolithiasis suffer from hypercal-
ciuria due to enhanced intestinal absorption of calcium
[10, 17]. Such patients may well respond differently to cal-
cium restriction than those with normal intestinal calcium
absorption.
The above predictions were met. Dietary modification
restriction significantly decreased urinary calcium. The
fall in urinary calcium was 29% in group I with moderate-
severe hypercalciuria, 19% in group II with mild hyper-
calciuria and 10%, in group III with normocalciuria.
Urinary oxalate did not change significantly due to
concurrent dietary oxalate restriction consistent with a
prior report [3]. In prior epidemiologic studies [1, 2], a
higher incidence of stones among subjects in the low-
est quintile of calcium intake was attributed to reduced
binding of oxalate in the bowel during calcium restric-
tion that increased urinary oxalate excretion. The lack of
a change in urinary oxalate disclosed here suggests that
a simultaneous dietary oxalate restriction may overcome
the so-called “calcium-oxalate interaction” in the bowel
and avert compensatory rise in urinary oxalate during
calcium restriction.
One might have expected that the reduced urinary cal-
cium in a setting of unaltered urinary oxalate would have
produced an equivalent decline in urinary saturation of
calcium oxalate. Such was not the case, since RSR of cal-
cium oxalate decreased less prominently compared to the
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fall in urinary calcium, or not at all, following dietary mod-
ification. We offer the following metabolic and physico-
chemical alterations for this finding.
As described under the section on calculation of ac-
tivity products in Methods, urinary saturation of calcium
oxalate is estimated from the activity product of calcium
oxalate (aCa2+ × aOx2−), where the ionic activity (aCa2+ or
aOx2−) is the product of concentration of calcium or ox-
alate ion and activity coefficient c. Dietary modification
can modify the activity product, by altering the forma-
tion of soluble complexes that affect the concentration of
calcium and oxalate ions, and by changing c.
During dietary modification, urinary citrate decreased,
probably due to reduced dietary alkali load from avoid-
ance of dairy products. This conclusion is supported by
reduced urinary pH, and tendency toward higher urinary
ammonium. Thus, the amount of calcium-citrate com-
plexes decreased. The amount of calcium-oxalate com-
plex also decreased during dietary modification from the
decline in urinary calcium without a change in urinary
oxalate. The reduced complex formation meant that less
of total calcium or oxalate was complexed, leaving a rela-
tively higher amount of [Ca2+] or [Ox2−]. Urinary sodium
substantially declined during dietary modification, reflec-
tive of sodium restriction. Since sodium is the main cation
of urine, urinary ionic strength decreased with reduced
urinary sodium, increasing c. The increased c led to a
higher fraction of [Ca2+] or [Ox2−] as ionic activity. Thus,
the decline in aCa2+ following dietary modification was
less marked compared with the fall in urinary calcium,
owing to reduced complexation and an increase in c. Con-
versely, aOx2− slightly increased with dietary modification
because of unaltered total oxalate, reduced calcium ox-
alate complex, and an increase in c.
Due to above physicochemical changes, aCa2+ × aOx2−
decreased less prominently than the decline in urinary
calcium during dietary modification. In group I with
moderate-severe hypercalciuria, the decline in RSR of
calcium oxalate of 12% was still significant, though less
than the fall in urinary calcium of 29%. RSR declined
slightly by 6% in group II with mild hypercalciuria, com-
pared with 19% in urinary calcium. In group III with nor-
mocalciuria, RSR did not change significantly, whereas
urinary calcium declined by 10%.
The effects of dietary modification on the RSR brushite
and monosodium urate were more consistent among the
3 groups. Besides reducing urinary calcium, dietary mod-
ification decreased urinary phosphorus and lowered uri-
nary pH (which reduced dissociation of phosphate). Thus,
RSR of brushite decreased significantly with dietary mod-
ification. The decline was still greater in hypercalciuric
groups (31% and 22%) than in normocalciuria (17%),
reflective of relative changes in urinary calcium.
Urinary uric acid decreased marginally or did not
change during dietary modification. Owing largely to
a decline in urinary sodium, urinary saturation of
monosodium urate declined in all 3 groups. The amount
of undissociated uric acid did not change following di-
etary modification in all 3 groups, since the decline in uri-
nary uric acid was compensated for by reduced urinary
pH (that retarded dissociation of uric acid).
The findings from this study should not be confused
with an earlier analysis from our stone registry reported
in this journal [5], in which urinary calcium was shown to
be equally effective as urinary oxalate in enhancing the
urinary saturation of calcium oxalate. That study exam-
ined the effect of calcium and oxalate alone, with patients
divided according to varying ranges of urinary calcium
or oxalate. In contrast, this study evaluated the effect
of dietary modification in which dietary calcium as well
as other components was restricted. The current effort
therefore was not directed at examining the relative im-
portance of urinary calcium and oxalate; rather, it was
concerned with the examination of the effect of dietary
modification that involved restriction of not only calcium
but other components.
The varying hypocalciuric response to dietary modifi-
cation among the 3 groups enumerated above was prob-
ably due to both metabolic and nutritional factors. The
metabolic disturbance of absorptive hypercalciuria type
I [24] with intestinal hyperabsorption of calcium was dis-
closed in 74% of patients in group I, 63% in group II, and
no one in group III. The dependence of urinary calcium
on dietary calcium is known to be accentuated in this con-
dition [10]. Thus, the decrement in urinary calcium from
reduced calcium intake is likely to be more prominent in
hypercalciuric groups than in the normocalciuric group.
Dietary factors probably also contributed to the differ-
ences in the hypocalciuric response among the 3 groups.
During the random diet, estimated calcium intake was
high in 52% of patients in group I, 25% in group II, and
11% in group III. In group I, 88% of patients took more
calcium during the random diet than during the restricted
diet, compared with 86% in group II and 68% in group
III. Moreover, the highest amounts of oxalate, sodium,
and meat were ingested by patients with moderate-severe
hypercalciuria (group I), intermediate amounts by those
with mild hypercalciuria (group II), and lowest amounts
by patients with normocalciuria (group III).
Commensurate with differing dietary intakes, group
I with moderate-severe hypercalciuria displayed highest
values for urinary calcium, oxalate, citrate, magnesium,
phosphorus, sodium, and uric acid (during the random
diet), as well as endogenous creatinine clearance, urinary
creatinine, and BMI. Group II with mild hypercalciuria
showed intermediate values and group III with normo-
calciuria lowest values. Thus, by virtually being bigger,
hypercalciuric patients appeared to have consumed more
food with higher amounts of calcium, oxalate, alkali, mag-
nesium, phosphorus, sodium, and purines.
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Probably reflective of varying intakes during the
random diet, the decrement in urinary sodium and phos-
phorus following dietary modification was more promi-
nent in hypercalciuric groups than in the normocalciuric
group. It is well known that sodium restriction (as shown
by reduced urinary sodium) lowers urinary calcium [11],
especially among patients with hypercalciuria. Thus, the
more prominent decline in urinary sodium could have
contributed to the greater decrement in urinary calcium
in groups I and II compared with group III. On the other
hand, a reduced phosphate intake (shown by a decline in
urinary phosphorus) is believed to increase urinary cal-
cium [25, 26]. The more prominent reduction in urinary
phosphorus among hypercalciuric groups may have op-
posed the effect of sodium cited above.
Thus, the more prominent hypocalciuric response to
dietary modification in hypercalciuric groups compared
to the normocalciuric group probably reflects enhanced
intestinal calcium absorption, a higher intake of calcium
and other nutrients during the random diet, and greater
decrement in certain urinary constituents (for example,
sodium). In contrast, the modest decline in urinary cal-
cium among the normocalciuric group may have resulted
from the normal state of intestinal calcium absorption, a
lower intake of calcium and other nutrients, and smaller
decrement in certain urinary constituents.
The aforementioned analysis of dietary modification
allows us to offer the following dietary-pharmacologic
guidelines in the medical management of calcium
nephrolithiasis. We suggest that the intake of oxalate,
sodium, and meat products should be limited in all pa-
tients. We concur that a high fluid intake should be
encouraged, though not applied in our dietary modifi-
cation owing to its diagnostic intent. Among patients
with urinary calcium >6.88 mmol/day, the dietary calcium
might be restricted to about 10 mmol/day. Trichlorme-
thiazide or indapamide might be given to further lower
urinary calcium, and potassium citrate provided to
avert hypokalemia and accentuate the hypocalciuric ac-
tion [27]. Among patients with urinary calcium 5.00 to
6.88 mmol/day, dietary calcium might be held to about
20 mmol/day, and potassium citrate offered. Among nor-
mocalciuric patients, we suggest a liberal calcium intake,
along with potassium citrate. The use of potassium citrate
among patients with mild hypercalciuria and normocal-
ciuria is justified because urinary citrate was low normal
and lower in these groups than in moderate-severe hy-
percalciuria. Urinary calcium loss might be averted by
the provision of potassium alkali [27], and urinary [Ca2+]
might be reduced from induced hypercitraturia that aug-
ments calcium-citrate complexation. This approach is
consistent with the management format imposed in 2
long-term drug trials from our group. Among patients
with AH-I (analogous to group I), dietary calcium intake
was held at 10 mmol/day along with restriction of oxalate
and sodium, while treatment with thiazide/indapamide
and potassium citrate was provided [28]. Among patients
with less severe AH-I and normocalciuria, the mean di-
etary calcium intake was 20 mmol/day and potassium
citrate treatment alone was provided [29]. Both manage-
ment programs not only averted stone formation, but also
maintained or increased bone density [28, 29], allaying
concern over bone loss that may ensue from calcium re-
striction.
CONCLUSION
Secondary hyperoxaluria from calcium restriction
can be avoided by concurrent oxalate restriction. The
hypocalciuric response to dietary modification was great-
est for patients with moderate-severe hypercalciuria, in-
termediate for those with mild hypercalciuria, and least
for normocalciuric patients. Because of various physic-
ochemical changes that altered aCa2+ × aOx2− , RSR of
calcium oxalate decreased modestly in moderate-severe
hypercalciuria, slightly in mild hypercalciuria, and not at
all in normocalciuria. The decline in urinary saturation
of brushite in the 3 groups was also less prominent in
normocalciuria than in hypercalciuria, corresponding to
the relative changes in urinary calcium. Assuming uri-
nary saturations of calcium oxalate and brushite play a
key role in calcium stone formation, dietary calcium re-
striction as a part of a broad dietary modification might
have a modest value in moderate-severe hypercalciuria,
slight value in mild hypercalciuria, and a negligible value
in normocalciuria.
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